Time：2023-09-24 16:32:55 View:
From September 20th to 24th, 2023, Professors Han Feng and Lu Yingmei from The research group led over ten representatives of teachers and students to Beijing to attend The 12th World Congress of Microcirculation. The World Microcirculation Conference was held in Beijing, China from September 20th to 24th, 2023. It was entrusted by the International Federation of Microcirculation and jointly organized by the Chinese Society of Microcirculation and the International Federation of Microcirculation, with the approval of the China Association for Science and Technology. Experts and scholars in the field of microcirculation from all over the world gathered at this grand event, including 35% of foreign scholars from North America, Europe, Australia and Asia, as well as about 750 key members of 18 professional committees of the Chinese Society of MicroCirculation, who participated in both offline and online conferences.
The World Microcirculation Congress is held every four years in rotation in Europe, the United States and the Asia-Pacific region, and is known as the "Olympics of the Microcirculation field". This congress is the first world-class microcirculation congress held in China since the establishment of the International Microcirculation Federation 48 years ago. The conference attaches great importance to interdisciplinary exchanges, gathering experts and scholars from the fields of basic and clinical microcirculation. It provides an international high-level academic platform for professors, scholars, young researchers and students from all over the world to exchange the latest research achievements in the basic, clinical and pharmaceutical aspects of microcirculation.
Each teacher and student in the research group gave an oral presentation and poster display in English respectively. Among them, Professor Han Feng was invited to give a presentation titled "Pharmacological target of." in the Symposium 31 special topic "Cerebral microvascular injury and pharmacological intervention" Invited report on "neurovascular unit in cerebrovascular disease" and chair of three symposiums. At the meeting, Professor Han Feng had an in-depth discussion with the attending experts and scholars on the correlation mechanism of intercellular communication and signal transduction in the neurovascular network based on the neurovascular unit, providing new ideas for clarifying the complex pathological mechanisms and regulatory targets of major brain diseases. Professor Yingmei Lu gave a special presentation at Satellite Symposium2: "From Microcirculation and Vascular Biology to Drug Target". The report elaborates in depth on the role of endothelial cell Sema3G in vascular remodeling. The research results reveal the significance of Sema3G in regulating the pathological process of ischemic retinopathy and the molecular mechanisms mediating pathological neovascularization, degeneration and remodeling. An important step has been taken in promoting the research on new drug targets for the clinical treatment of ischemic retinopathy.
On the morning of September 21st, Wu Zhouyue reported on her research work in the fields of new targeted anti-tumor drugs and new anti-glioma drug delivery systems. On the afternoon of September 21st, Associate Professor Liu Xiuxiu presented her research on the mechanism of endothelial cdk5 knockout mediating refractory epilepsy at the Youth Symposium. On the morning of September 22nd, Zhang Quanxin, a student, reported on the therapeutic significance of protease B inhibitors in the treatment of neuroinflammation during autism. On the afternoon of September 22nd, Associate Professor Sun Meiling, Dr. Li Zhengmao, Student Shi Yi and Student Cheng Jiawen respectively presented at Symposium 26: Vascular Redox Signaling and Oxidative Stress and Free Oral Communication 10: New Methods and New Techniques reported on multiple aspects such as adverse reactions of chemotherapy drugs, nitrification stress, and virus injection strategies. On the morning of September 23rd, Chen Xiang, a student, presented a research report on the aggravation of peripheral vascular constriction induced by air pollution through AT1R upregulation due to endothelial-derived Cdk5 deficiency in vascular high permeability. On the morning of September 24th, Dr. MAO Xingfeng and Lin Lishan respectively reported on the regulatory effects of the key molecules SENP1 and GPR124 after cerebral ischemia. In the poster display area, Dr. Zhang Yixuan introduced the endothelial dysfunction induced by COVID-19 as an abnormal neurovascular immune cell communication network and discussed and exchanged views with scholars and experts at home and abroad.
At the award ceremony of the conference, Associate Professor Liu Xiuxiu, Associate Professor Sun Meiling, Dr. MAO Xingfeng, Shi Yi and Lin Lishan were awarded the Young Researcher Award, and Dr. Zhang Yixuan was awarded the Excellent Poster Award.
This conference not only provided a valuable opportunity for the representatives of teachers and students in the research group to exchange ideas with outstanding experts and scholars at home and abroad, but also offered a stage for young postgraduate students to bravely showcase their academic achievements. In the future, the research group will continue to actively promote the cross-disciplinary development, be courageous in innovation and exploration, and forge ahead with determination, contributing more wisdom and strength to the discovery of disease drug targets and the research and development of innovative drugs.